Literature DB >> 10854849

Differential degradation of calpastatin by mu- and m-calpain in Ca(2+)-enriched human neuroblastoma LAN-5 cells.

R De Tullio1, M Averna, F Salamino, S Pontremoli, E Melloni.   

Abstract

In neuroblastoma LAN-5 cells during calpain activation, in addition to the two expressed 70 kDa and 30 kDa calpastatin forms, other inhibitory species are produced, having molecular masses of 50 kDa and 15 kDa. At longer times of incubation, both native and new calpastatin species disappear. The formation of these new calpastatins as well as the decrease in intracellular total calpastatin activity are mediated by calpain itself, as indicated by the effect of the synthetic calpain inhibitor I, which prevents both degradative processes. Analysis of the calcium concentrations required for the two processes indicates that the first conservative proteolytic event is mediated by micro-calpain, whereas the second one is preferentially carried out by m-calpain. The appearance of the 15 kDa form, containing only the calpastatin repetitive inhibitory domain and identified also in red cells of hypertensive rats as the major inhibitor form, can be considered a marker of intracellular calpain activation, and it can be used for the monitoring of the involvement of calpain in pathological situations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854849     DOI: 10.1016/s0014-5793(00)01613-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Calpastatin domain L is a partial agonist of the calmodulin-binding site for channel activation in Cav1.2 Ca2+ channels.

Authors:  Etsuko Minobe; Hadhimulya Asmara; Zahangir A Saud; Masaki Kameyama
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

2.  Identification and characterization of a novel expandable adult stem/progenitor cell population in the human exocrine pancreas.

Authors:  M A Puglisi; L Giuliani; A Fierabracci
Journal:  J Endocrinol Invest       Date:  2008-06       Impact factor: 4.256

3.  In vivo administration of calpeptin attenuates calpain activation and cardiomyocyte loss in pressure-overloaded feline myocardium.

Authors:  Santhosh K Mani; Hirokazu Shiraishi; Sundaravadivel Balasubramanian; Kentaro Yamane; Meenakshi Chellaiah; George Cooper; Naren Banik; Michael R Zile; Dhandapani Kuppuswamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

4.  Adaptive modifications in the calpain/calpastatin system in brain cells after persistent alteration in Ca2+ homeostasis.

Authors:  Roberto Stifanese; Monica Averna; Roberta De Tullio; Marco Pedrazzi; Francesco Beccaria; Franca Salamino; Marco Milanese; Giambattista Bonanno; Sandro Pontremoli; Edon Melloni
Journal:  J Biol Chem       Date:  2009-10-30       Impact factor: 5.157

5.  Characterization of a new p94-like calpain form in human lymphocytes.

Authors:  Roberta De Tullio; Roberto Stifanese; Franca Salamino; Sandro Pontremoli; Edon Melloni
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

6.  Role and differential expression of calpastatin mRNA and protein in cultured cardiomyocytes exposed to hypoxic stress.

Authors:  Huey Lin; Milish P Risbood; Atul Jain; Victor Vacanti; Techung Lee
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

7.  Clinical severity of β-thalassaemia/Hb E disease is associated with differential activities of the calpain-calpastatin proteolytic system.

Authors:  Suriyan Sukati; Saovaros Svasti; Roberto Stifanese; Monica Averna; Nantika Panutdaporn; Tipparat Penglong; Edon Melloni; Suthat Fucharoen; Gerd Katzenmeier
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

8.  Interference with Ca2+-Dependent Proteolysis Does Not Alter the Course of Muscle Wasting in Experimental Cancer Cachexia.

Authors:  Fabrizio Pin; Valerio G Minero; Fabio Penna; Maurizio Muscaritoli; Roberta De Tullio; Francesco M Baccino; Paola Costelli
Journal:  Front Physiol       Date:  2017-04-19       Impact factor: 4.566

9.  Unexpected role of the L-domain of calpastatin during the autoproteolytic activation of human erythrocyte calpain.

Authors:  Roberta De Tullio; Alice Franchi; Antonino Martines; Monica Averna; Marco Pedrazzi; Edon Melloni; Bianca Sparatore
Journal:  Biosci Rep       Date:  2018-04-20       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.